Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001658062 | SCV000289361 | likely benign | not provided | 2025-01-27 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000575050 | SCV000676213 | likely benign | Hereditary cancer-predisposing syndrome | 2015-07-15 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001658062 | SCV001874899 | likely benign | not provided | 2020-11-11 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002487078 | SCV002801258 | likely benign | Colorectal cancer, susceptibility to, 12; Facial dysmorphism-immunodeficiency-livedo-short stature syndrome; Intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, genital anomalies, and immunodeficiency | 2022-05-25 | criteria provided, single submitter | clinical testing | |
KCCC/NGS Laboratory, |
RCV000229137 | SCV004017065 | likely benign | Colorectal cancer, susceptibility to, 12 | 2023-07-07 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001658062 | SCV005217324 | likely benign | not provided | criteria provided, single submitter | not provided |